The FDA puts its highest-risk Class I label on Medtronic’s recall of its Duet system, used to drain cerebrospinal fluid and monitor intracranial pressure.
The FDA today slapped medtech titan Medtronic (NYSE:MDT) with its highest-risk label on a recall of the company’s Duet external drainage & monitoring systems.
The device, part of Medtronic’s Neurosurgery division, helps continuously drain cerebrospinal fluid and monitor intracranial pressure under supervision from a trained clinician.
Help employers find you! Check out all the jobs and post your resume.
